No abstract available
MeSH terms
-
Animals
-
Clinical Trials, Phase II as Topic / methods
-
Clinical Trials, Phase II as Topic / trends*
-
Humans
-
Integrin alpha4beta1 / antagonists & inhibitors*
-
Integrin alpha4beta1 / immunology
-
Integrins / antagonists & inhibitors
-
Integrins / immunology
-
Multiple Sclerosis / drug therapy*
-
Multiple Sclerosis / immunology
Substances
-
Integrin alpha4beta1
-
Integrins